A deletion mutant of Listeria monocytogenes lacking OpuC, an ABC transporter responsible for the uptake of the compatible solute carnitine, was constructed and carnitine transport assays confirmed that carnitine transport was defective in this mutant. However, the mutant retained the ability to derive osmoprotection from carnitine, suggesting the presence of a second uptake system for this compatible solute. Measurement of intracellular carnitine pools during balanced growth confirmed that the opuC mutant accumulated high levels of carnitine. These pools were only achieved in the mutant when high levels (1 mM) of carnitine were present extracellularly. When a lower level (100 WM) was supplied in the medium the mutant failed to accumulate a substantial intracellular pool and failed to derive osmoprotection from carnitine. These data suggest the presence of a second low affinity carnitine uptake system in this osmotolerant pathogen. ß
Introduction
The food-borne pathogen Listeria monocytogenes is able to tolerate harsh environmental stresses, such as reduced water activity, and refrigeration temperatures [1, 2] . Like many other organisms L. monocytogenes responds to conditions of hyperosmotic stress by accumulating osmotically active compounds, termed compatible solutes. The accumulation of compatible solutes acts to counteract the outward £ow of water, thereby maintaining cell turgor within reasonable limits [3^5] . L. monocytogenes has been shown to utilise two related quaternary amine compounds as compatible solutes, L-betaine [6] and L-carnitine [7] .
Verheul et al. [8] showed that carnitine accumulation in L. monocytogenes is mediated by a transporter with a high a⁄nity for carnitine : a K m of 10 WM and a V max of 48 nmol min 31 (mg cell protein) 31 . Transport of carnitine is independent of the osmolarity of the assay medium and is subject to negative regulation by pre-accumulated carnitine, betaine and unidenti¢ed components of peptone [8, 9] . Betaine is known to be transported by at least two separate transport systems, the sodium solute symporter, BetL [10] , and the ABC transporter, Gbu [11] . Betaine uptake is una¡ected in the presence of 100 times excess carnitine, demonstrating that these systems are speci¢c for betaine and do not play a role in the accumulation of carnitine [12] .
Recently we reported the identi¢cation of a high a⁄nity carnitine transport system in L. monocytogenes, based on homology to the OpuC transporter of Bacillus subtilis [13] . This transporter, designated OpuC, belongs to the binding protein-dependent ABC transporter subfamily. OpuC is encoded by a four-gene operon, opuCABCD. The ATPase subunit is encoded by opuCA, the permease subunits by opuCB and opuCD and the substrate binding protein by opuCC [13] .
A mutant of L. monocytogenes EGD in which the opuC operon has been insertionally inactivated using the suicide vector pAULA [14] is defective in its ability to transport carnitine, but not the related compounds betaine and choline [13] . Competition experiments have shown that OpuC is speci¢c for carnitine, although competition was seen with the related compounds acetylcarnitine and Q-butyro-betaine [8] . The opuCA : :pAULA mutant shows reduced growth on complex medium with added NaCl (4% w/v) compared to the wild-type parent strain, indicating that this transporter plays an important role in osmoregulation. Unusually, the opuC : :pAULA mutant strain exhibits poor growth in a de¢ned medium, a defect that is rescued by the supplementation of the medium with peptone [13] .
Here we describe the construction of an opuCA deletion strain and present evidence for a previously unidenti¢ed low a⁄nity carnitine transporter in L. monocytogenes.
Materials and methods

Strains and growth experiments
The wild-type L. monocytogenes serotype 1/2a strain EGD and a vopuCA derivative of this strain were used throughout. Growth experiments were carried out in de¢ned medium (DM), as previously described [15] . The medium osmolarity was raised by the addition of NaCl. Experiments were carried out in duplicate on the day, and repeated independently at least twice. Representative growth data are shown, whilst speci¢c growth rates are described as means þ S.D.
Construction of opuCA deletion mutant
An in-frame deletion mutant was constructed by PCR (splicing by overlap extension) SOEing, as described previously [16] . The oligonucleotide primers used to generate the deletion were as follows: P160 (5P-ccgtttatctttatccacgttaagtgttagatc-3P), P124 (5P-ttacttgagtgtgctatctttgc-3P), P161 (5P-gtggataaagataaacggcttgtcggaattgttac-3P) and P111 (5P-tcctagtccaccagctccaatg-3P). Primer 160 included an 18-bp tail, complementary to 18 bp of primer 161 (underlined sequence). The suicide vector pKSV7 was used to introduce the opuCA deletion into EGD, as described previously [17] . The presence of the chromosomal opuCA deletion was con¢rmed by PCR using primers P130 (5P-gtagtaatacgctgaataacgcg-3P) and P123 (5P-cgatgtggaagcagaaac-3P). The 2.1-kb PCR product resulting from this reaction was sequenced on both DNA strands and the presence of an in-frame 1-kb deletion in the opuCA gene (removing amino acid residues 25^321 from the OpuCA protein) was con¢rmed. The absence of vector sequences in the deletion mutant was con¢rmed by PCR using primers Pfor (5P-tgtaaaacgacggccagt-3P) and Prev (5P-caggaaaccagctatgac-3P).
Carnitine transport assays
The uptake of carnitine was measured as previously described [13] . When measuring transport in the presence of di¡ering concentrations of carnitine, secondary stock solutions were created with unlabelled carnitine to give a ¢nal carnitine concentration of 100 WM or 1 mM when added to the cell suspension. [ 3 H]Carnitine-HCl (Amersham Pharmacia Biotech) was added to this secondary stock at a ¢xed speci¢c activity (29.9 WCi Wmol 31 ). The rate of carnitine accumulation was determined by calculating the slope of the line of the linear part of the uptake curve. The total cell protein values used to calculate solute pools were 170 Wg ml 31 OD 600 unit 31 at low osmolarity and 130 Wg ml 31 OD 600 unit 31 at high osmolarity, as previously described [15] .
Measurement of steady-state solute pools
Steady-state cytoplasmic carnitine pools were determined as previously described [13] . For measurement of pools in the presence of 1 mM or 100 WM carnitine, carnitine at these concentrations was added to the growth media at a ¢xed speci¢c activity of 300 nCi Wmol 31 of [ 3 H]carnitine-HCl.
Results
Construction of opuCA deletion mutant
Previously we reported the generation of an opuC : : pAULA disruption mutant, which failed to grow in DM, a phenotype that was rescued by the addition of peptone to the growth media [13] . In subsequent experiments we found that L. monocytogenes EGD (pAULA) displayed a similar growth defect in DM (data not shown). To resolve this problem a deletion mutant lacking opuCA, the ¢rst gene of the opuC operon, was constructed as described in Section 2.
In order to con¢rm that the vopuCA mutant was de¢-cient in carnitine transport, the ability of the vopuCA cells to accumulate carnitine was investigated using tritiated ( 3 H) carnitine (20 WM). In wild-type cells carnitine is accumulated at a rate of V120 nmol min 31 (mg cell protein)
31 , regardless of the presence or absence of added NaCl (Fig. 1) , con¢rming previous ¢ndings that carnitine uptake is not salt activated [8, 9] . In the vopuCA mutant carnitine transport is almost entirely abolished, with only a small amount of residual activity remaining (V1 nmol min 31 (mg cell protein) 31 ). These data con¢rmed that the opuCA deletion disrupted the activity of the major carnitine transporter in L. monocytogenes.
The vopuCA mutant was tested for its ability to grow in DM. The deletion mutant grew with a similar speci¢c growth rate to the wild-type (0.45 h 31 and 0.47 h 31 , respectively), suggesting that the growth defect in DM observed for the opuC: :pAULA mutant was not due to the lack of the OpuC transport system.
The vopuCA mutant can use carnitine as an osmoprotectant
We investigated the ability of the vopuCA mutant strain to utilise carnitine as an osmoprotectant in DM, an experiment we were unable to perform with the opuCA: :pAU-LA mutant because of its impaired growth in DM [13] . This was done by measuring growth at increased osmolarities in the presence or absence of carnitine. There was no di¡erence in the growth rate between the wild-type and vopuCA strain in DM. There was a reduction of approximately 50% in growth rate of both wild-type and mutant strains in the presence of 0.5 M NaCl (Fig. 2) . The addition of 1 mM carnitine to DMS resulted in increased growth in both strains. The speci¢c growth rates of wildtype and vopuCA mutant were identical, 0.26 ( þ 0.01) h 31 and 0.26 ( 6 0.01) h 31 , respectively, representing an increase of approximately 25% in growth rate (Fig. 2) . The wild-type and mutant behaved similarly when 0.8 M NaCl was used to raise the medium osmolarity (data not shown). These data show that cells lacking opuCA retain the ability to utilise carnitine as an osmoprotectant. This result was surprising since we expected the disruption of a major carnitine transport system to lead to a loss of osmoprotection by carnitine.
Carnitine accumulation in the vopuCA mutant
To determine how the vopuCA deletion a¡ected the accumulation of carnitine in growing cells, the cytoplasmic carnitine pools during balanced growth in DM with 1 mM carnitine, with or without 0.5 M NaCl, were measured. In the absence of added salt the vopuCA mutant possesses a carnitine pool approximately half the size of the wild-type.
When cells are grown in the presence of 0.5 M NaCl, both the wild-type and vopuCA mutant cells show a large increase in the cytoplasmic carnitine pool (Fig. 3A) . Although the ¢nal pool in the vopuCA mutant is reduced compared to the wild-type (1031 nmol (mg cell protein) 31 and 1549 nmol (mg cell protein) 31 , respectively), clearly this substantial pool is su⁄cient to allow the osmoprotection observed under the growth conditions tested (Fig. 2) . These data pointed to the presence of an additional carnitine uptake system, that could compensate for the lack of functional OpuC in the presence of high extracellular carnitine concentrations (1 mM).
Next we investigated whether this alternative carnitine uptake system could generate a cytoplasmic pool of carnitine when the extracellular concentration of this compatible solute was lowered from 1 mM to 100 WM. The wildtype cells accumulated pools similar in size to those accumulated in the presence of 1 mM carnitine, suggesting that carnitine was not limiting at this concentration. However, the intracellular pool of carnitine accumulated by the vopuCA mutant was reduced signi¢cantly compared to the pool observed in the mutant growing in the presence of 1 mM extracellular carnitine (Fig. 3A,B) . The addition of 0.5 M NaCl led to a 6-fold increase in pool size, but the steady-state pool size was still approximately 90% lower than the wild-type in the same medium (168 nmol (mg cell protein) 31 and 1940 nmol (mg cell protein) 31 , respectively) (Fig. 3B) . These data show that the size of the carnitine pool is dependent on the carnitine concentration in the growth medium and point to the presence of a previously uncharacterised low a⁄nity carnitine transport system in L. monocytogenes.
The existence of a low a⁄nity uptake system is also suggested by measurements of the rate of carnitine transport in the presence of either 1 mM or 100 WM. The rate of carnitine transport seen by the wild-type strain is not a¡ected by the reduction in substrate concentration from 1 mM to 100 WM carnitine (Fig. 4A,B) , consistent with the known high a⁄nity of OpuC for carnitine (apparent K m is approximately 10 WM [8] ). However, the vopuCA strain only shows detectable uptake of carnitine in the presence of 1 mM carnitine (Fig. 4A,B) , suggesting that the remaining uptake system has a lower a⁄nity for this compatible solute than OpuC.
Carnitine transport in the absence of OpuC is insu⁄cient for osmoprotection in the presence of low carnitine concentrations
The transport data above suggested a possible explanation for the ability of 1 mM carnitine to act as an osmoprotectant when the vopuCA mutant was in DM with 0.5 M added NaCl (Fig. 2) ; that is, the low a⁄nity uptake system(s) present in the mutant could accumulate su⁄cient carnitine to allow osmoprotection and therefore an enhanced growth rate. To test this we performed a growth experiment where the wild-type and vopuCA mutant were grown in high osmolarity medium (DM, 0.5 M NaCl) with or without 100 WM carnitine. Under these conditions the wild-type showed an increased growth rate (approximately 20%) compared to the control, which had no added carnitine. However, the vopuCA mutant was unable to use this low concentration of carnitine as an osmoprotectant and no signi¢cant increase in the growth rate was detected (Fig. 5 ).
Discussion
Here we have described the construction and characterisation of an in-frame deletion mutant of L. monocytogenes, which lacks the ATPase subunit of the OpuC transporter, a high a⁄nity carnitine uptake system that belongs to the ABC transporter superfamily. The vopuCA mutant grows normally in our DM and there is no evidence of impaired growth even when the osmolarity of the growth medium is raised with 0.5 M NaCl (Fig. 2) . This is in contrast to an insertion mutant (opuCA: :pAULA) that we have described previously ; this mutant failed to grow in DM, a phenotype that we attributed to the loss of the OpuC uptake system [13] . We now know that this phenotype is due to the presence of pAULA DNA in this strain and not the loss of the OpuC transporter. Although the reason for the growth defect of this strain in DM remains unknown, this observation highlights the potential problems associated with using suicide plasmids to generate mutations by insertional inactivation.
We show here that the uptake of carnitine was reduced dramatically in an vopuCA mutant when we performed [ 3 H]carnitine uptake assays (Fig. 1) . This result was surprising since this mutant is not impaired in its ability to use carnitine as an osmoprotectant, when this compatible solute is present in the growth medium at a concentration of 1 mM (Fig. 2) . This apparent paradox is resolved by the observation that the vopuCA mutant retains the ability to accumulate a substantial cytoplasmic pool of carnitine during exponential growth (Fig. 3) and the rate of carnitine accumulation is near-wild-type when it is present extracellularly at a concentration of 1 mM (Fig. 4) . When the concentration of carnitine is lowered to 100 WM the rate of uptake is impaired severely (Fig. 4) and the intracellular pool achieved during balanced growth is reduced to a level that is insu⁄cient to confer osmoprotection (Figs. 3 and 5 ). These data provide evidence for a second carnitine uptake system in L. monocytogenes EGD and suggest that this system has a low a⁄nity for carnitine. Furthermore, the steady-state pool data demonstrate that this transporter is subject to osmotic regulation (either at the level of expression or transport activity), since the pool accumulated in the presence of 0.5 M NaCl is approximately 5-fold greater than in the absence of added NaCl (Fig. 3) .
The identity of the low a⁄nity uptake system described here remains to be established. Two other compatible transport systems have been identi¢ed in L. monocytogenes, BetL and Gbu [10, 11] . Neither of these systems is likely to account for the low a⁄nity carnitine transport observed, since transport experiments have shown that they are speci¢c for betaine; the presence of excess unlabelled carnitine has no e¡ect on the accumulation of radiolabelled betaine [12] . The recent publication of the L. monocytogenes EGD genome sequence [18] has enabled us to perform in silico searches for potential carnitine transporters using the ListiList internet site (http://genolist.pasteur.fr/ListiList/). Interestingly, two ORFs (lmo1421 and lmo1422), located approximately 2.4 kb downstream from the opuC operon, are predicted to encode proteins with considerable sequence similarity to the subunits of the OpuC transporter, as well as to compatible solute transporters from other bacterial genera. Based on a closer inspection of their sequences (BLAST searches and hydropathy pro¢ling), lmo1421 and lmo1422 are predicted to encode an ATPase subunit and a permease^substrate binding subunit, respectively. Further experiments are underway to determine if these genes encode the low af¢nity carnitine transport system that we have described here. 
